Release Summary

Elixir presents outstanding 5yr Clinical Data for CE Mark-approved DESolve® & 6mo Safety & Efficacy Results for Next-Gen Thin-strut DESolve® Cx Novolimus Eluting Bioresorbable Coronary Scaffolds.

Elixir Medical Corporation